- Moderna Inc will make certain milestone payments to the U.S. National Institutes of Health related to the COVID-19 vaccines.
- CDC expert advisory group said there is not sufficient evidence to recommend more than one COVID-19 booster shot a year.
- Pfizer Inc and BioNTech SE filed an application to the U.S. FDA for full approval of their adapted COVID-19 vaccine.
Moderna to make milestone payments to NIH for COVID vaccine
Moderna Inc will make certain contingent development, commercial and regulatory milestone payments to the U.S. National Institutes of Health (NIH) related to the development of COVID-19 vaccines, the company said in a filing on Friday.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FBTHDFIYHVN4JEABRAC7TLP73I.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UFW4YPVTVFNAZARJEVUDPSPU74.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/6W5WJY7T4NLKVFJO5JX37LPYS4.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OGBROYPEZVMVNLCKMBDIE2XJCE.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BYL7ESQPMFMSNNVJSVCYKYTPH4.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JG3AL7UAGVPBJHJUNQS4YZL4SE.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FBTHDFIYHVN4JEABRAC7TLP73I.jpg&description=Moderna%20to%20make%20milestone%20payments%20to%20NIH%20for%20COVID%20vaccine){kind=link}